Clinical Trials Directory

Trials / Completed

CompletedNCT05472870

Efficacy and Mechanism of rTMS in Children With ASD: an Open-label Clinical Trial(Ⅱ)

Efficacy and Mechanism of Repeated Transcranial Magnetic Stimulation in Children With Autism Spectrum Disorder: an Open-label Clinical Trial(Ⅱ)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
All
Age
4 Years – 16 Years
Healthy volunteers
Not accepted

Summary

This study is a open-label clinical trial involving over 30 ASD children aged ≥4 years old. During the study, subjects received repeated transcranial magnetic stimulation (rTMS) intervention on the left primary motor cortex (M1) 10 times per day for 5 consecutive days and complete clinical assessments from pre-intervention to post-intervention. This study hopes to explore whether accelerated continuous theta-burst stimulation (a-cTBS) over left primary motor cortex (M1) can improve clinical symptoms of children with ASD in China.

Detailed description

This study is a single-arm open-label clinical trial, designed to enroll at least 30 children with ASD aged over 4 years old. During the trial, participants will receive accelerated continuous theta-burst stimulation (a-cTBS)on the left primary motor cortex (M1) for 5 consecutive days and complete clinical assessments within 2 weeks before the cTBS intervention (pre-cTBS), repeated within 3 days after the completion of the cTBS course (post-cTBS) and 1 month following the last cTBS session (one month follow-up), respectively. The purpose of this current study is to explore whether rTMS can improve the clinical symptoms of children with autism spectrum disorder in China, and to investigate the neurophysiological mechanism of rTMS for ASD children.

Conditions

Interventions

TypeNameDescription
DEVICErepetitive Transcranial Magnetic StimulationA technique that involves the use of electrical coils on the head to generate a brief magnetic field which reaches the cerebral cortex.

Timeline

Start date
2022-07-12
Primary completion
2022-12-15
Completion
2023-01-20
First posted
2022-07-25
Last updated
2024-08-21
Results posted
2024-08-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05472870. Inclusion in this directory is not an endorsement.